With the analysis among 736 patents, we discovered top 220 key players by total patent application. Oncolytics Biotech, Inc., Anthrogenesis Corp., Mesoblast International SARL are dominant in this area. They take 11.68% of the total patent filing.
Alberta, Canada
Patent: 40
New Jersey, United States
Patent: 24
Mesoblast International SARL
Washington, United States
Patent: 17
Medeor Therapeutics, Inc.
California, United States
Patent: 13
Regents of the University of California
California, United States
Patent: 11
California, United States
Patent: 11
Massachusetts, United States
Patent: 9
New Jersey, United States
Patent: 8
With the analysis among 44 patents, we discovered top 16 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, LifeScore Ltd., BostonGene Corp. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Massachusetts, United States
Patent: 6
Illinois, United States
Patent: 4
Technologies Morphocell, Inc.
California, United States
Patent: 2
Meril Life Sciences Pvt Ltd.
Daman and Diu, India
Patent: 1
Seaport Diagnostics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among related 241 patents applied in the last 5 years. We discover 88 most active companies in this area. The fast-growing Mesoblast International SARL, Juno Therapeutics, Inc., Medeor Therapeutics, Inc. take 20.75% of patent filing during this period.
Mesoblast International SARL
Washington, United States
Patent: 15
Medeor Therapeutics, Inc.
California, United States
Patent: 13
New York, United States
Patent: 7
Massachusetts, United States
Patent: 6
Asterias Biotherapeutics, Inc.
California, United States
Patent: 6
Korea University Reserch & Business Foundation
Saitama Medical University
Saitama-ken, Japan
Patent: 5
Gen Xi Biological Technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 5
Suzhou Genxi Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 5
With the analysis among related 241 patents in last 5 years, we discover 56 new entrants. Mesoblast International SARL, Medeor Therapeutics, Inc., Enochian Biopharma, Inc. are the most active new entrants in this area.
Mesoblast International SARL
Medeor Therapeutics, Inc.
California, United States
Patent: 13
New York, United States
Patent: 7
Massachusetts, United States
Patent: 6
Asterias Biotherapeutics, Inc.
California, United States
Patent: 6
Saitama Medical University
Saitama-ken, Japan
Patent: 5
Gen Xi Biological Technology (Shanghai) Co Ltd
Shanghai Shi, China
Patent: 5
Suzhou Genxi Biological Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 5
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Technologies Morphocell, Inc.
With the analysis among 245 patents, we discovered top 58 universities and scientific research institutions by total patent application. Emory University, Vrije Universiteit Brussel, University of Chile are dominant in this area. They take 20.41% of the total patent filing.
Georgia, United States
Patent: 13
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 10
Vlaams Instituut voor Biotechnologie - Flanders Institute
Institut Gustave Roussy EURL
The Johns Hopkins University School of Medicine
New York, United States
Patent: 5
Arizona, United States
Patent: 4